GLP-tox study reinforces favorable safety profile of Tiprelestat Phase II Study in Pulmonary Arterial Hypertension (PAH) to ...

December 02, 2025-- ILiAD Biotechnologies, LLC (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella Pertussis, today announced ...

This article is for CEOs, investors, and HR folks outside the US who want to get into or grow in the US biotech world. We'll ...

Tema ETFs (“Tema”), the New York-based manager of innovative exchange-traded funds (ETFs), is pleased to announce the Tema Oncology ETF (“CANC”) has surpassed $100m in assets under management (AUM) ...

Expanding applied higher education at the expense of academic higher education would be a strategic mistake, says TalTech ...

With a renewed focus on research experience and experiential learning, enrollment across undergraduate, master’s and PhD programs has grown to new levels, positioning students for success across ...

External Affairs Minister S. Jaishankar on December 1 warned that the threat of biological weapons and bioterrorism is no ...

Innatrix‘s lead product, InnaNema, targets soybean cyst nematode, one of the most damaging pests for U.S. soybean crops.

Recently, The Kuni Foundation sponsored a conversation with the Portland Business Journal about the challenges and ...

Founded by former Vice Chairman of NASDAQ David Weild IV, the Weild Foundation institutionalizes the successful playbook behind the JOBS Act.

Growing up as an Armenian diaspora means inheriting a certain kind of story — one shaped by survival, loss and the unwavering ...

Samsung Biologics has announced a massive investment of 7 trillion won (about USD 4.8 billion) to build its third bio campus in Songdo, Incheon, marking another step toward expanding its global ...